JP2020510660A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020510660A5 JP2020510660A5 JP2019546918A JP2019546918A JP2020510660A5 JP 2020510660 A5 JP2020510660 A5 JP 2020510660A5 JP 2019546918 A JP2019546918 A JP 2019546918A JP 2019546918 A JP2019546918 A JP 2019546918A JP 2020510660 A5 JP2020510660 A5 JP 2020510660A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- compound
- excipient
- composition according
- aqueous medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022017392A JP7498202B2 (ja) | 2017-03-01 | 2022-02-07 | Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762465675P | 2017-03-01 | 2017-03-01 | |
| US62/465,675 | 2017-03-01 | ||
| US201762468832P | 2017-03-08 | 2017-03-08 | |
| US62/468,832 | 2017-03-08 | ||
| US201762526039P | 2017-06-28 | 2017-06-28 | |
| US62/526,039 | 2017-06-28 | ||
| US201762530515P | 2017-07-10 | 2017-07-10 | |
| US62/530,515 | 2017-07-10 | ||
| PCT/US2018/020519 WO2018160882A1 (en) | 2017-03-01 | 2018-03-01 | Compositions comprising pgi2-receptor agonists and processes for the preparation thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022017392A Division JP7498202B2 (ja) | 2017-03-01 | 2022-02-07 | Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020510660A JP2020510660A (ja) | 2020-04-09 |
| JP2020510660A5 true JP2020510660A5 (https=) | 2021-03-25 |
| JP7023559B2 JP7023559B2 (ja) | 2022-02-22 |
Family
ID=61622823
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019546918A Active JP7023559B2 (ja) | 2017-03-01 | 2018-03-01 | Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス |
| JP2022017392A Active JP7498202B2 (ja) | 2017-03-01 | 2022-02-07 | Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022017392A Active JP7498202B2 (ja) | 2017-03-01 | 2022-02-07 | Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11123298B2 (https=) |
| EP (2) | EP3977985B1 (https=) |
| JP (2) | JP7023559B2 (https=) |
| KR (2) | KR20220119169A (https=) |
| CN (1) | CN110582271B (https=) |
| AU (2) | AU2018227842B2 (https=) |
| CA (1) | CA3054835A1 (https=) |
| ES (2) | ES2897024T3 (https=) |
| IL (1) | IL268997B2 (https=) |
| MA (1) | MA47686A (https=) |
| WO (1) | WO2018160882A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016065103A1 (en) | 2014-10-23 | 2016-04-28 | Arena Pharmaceuticals, Inc. | Method of treating conditions related to the pgi2 receptor |
| EP3977985B1 (en) | 2017-03-01 | 2023-09-06 | Arena Pharmaceuticals, Inc. | Compositions comprising pgi2-receptor agonists and processes for the preparation thereof |
| WO2019222764A1 (en) * | 2018-05-16 | 2019-11-21 | Arena Pharmaceuticals, Inc. | Compositions comprising pgi2-receptor agonists and processes for the preparation thereof |
| US12098116B2 (en) | 2022-02-15 | 2024-09-24 | United Therapeutics Corporation | Crystalline prostacyclin (IP) receptor agonist and uses thereof |
| WO2025009945A1 (ko) * | 2023-07-06 | 2025-01-09 | 재단법인대구경북과학기술원 | 셀렉시팍을 포함하는 퇴행성 뇌질환의 예방 또는 치료용 약학 조성물 |
| US20250282716A1 (en) | 2024-03-11 | 2025-09-11 | United Therapeutics Corporation | Methods of making ip-receptor agonists |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2945530A1 (de) | 1979-11-10 | 1981-06-04 | Chemische Werke Hüls AG, 4370 Marl | Harnstoffe mit cyclischen substituenten, ihre herstellung und verwendung als herbizide |
| JPH03160438A (ja) | 1989-11-20 | 1991-07-10 | Konica Corp | ハロゲン化銀カラー写真感光材料 |
| EP0442448A3 (en) | 1990-02-13 | 1992-08-12 | Bristol-Myers Squibb Company | Heterocyclic carboxylic acids and esters |
| CA2085844A1 (en) | 1991-12-27 | 1993-06-28 | Nobuyuki Hamanaka | Fused benzeneoxyacetic acid derivatives |
| JPH06329598A (ja) | 1993-05-19 | 1994-11-29 | Daicel Chem Ind Ltd | エステルの製造方法 |
| DE4318889A1 (de) | 1993-06-07 | 1994-12-08 | Bayer Ag | Verfahren zur Herstellung von organischen Carbamaten |
| US5558071A (en) * | 1994-03-07 | 1996-09-24 | Combustion Electromagnetics, Inc. | Ignition system power converter and controller |
| WO1995024393A1 (en) | 1994-03-10 | 1995-09-14 | Fujisawa Pharmaceutical Co., Ltd. | Naphthalene derivatives as prostaglandin i2 agonists |
| GT199800126A (es) | 1997-08-29 | 2000-01-29 | Terapia de combinacion. | |
| JPH11269138A (ja) | 1998-03-20 | 1999-10-05 | Mitsubishi Paper Mills Ltd | 有機塩基発生剤 |
| US6335459B1 (en) | 1998-12-23 | 2002-01-01 | Syntex (U.S.A.) Llc | Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators |
| GB9908934D0 (en) | 1999-04-19 | 1999-06-16 | Rolic Ag | Liquid crystalline compounds |
| EP1046631A1 (en) | 1999-04-19 | 2000-10-25 | Rolic AG | Liquid crystalline compounds |
| US20040048844A1 (en) | 1999-10-20 | 2004-03-11 | Bristol-Myers Squibb Pharma Company | Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| IL134830A0 (en) * | 2000-03-01 | 2001-05-20 | Chay 13 Medical Res Group N V | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
| MXPA02009031A (es) * | 2000-03-14 | 2004-08-19 | Amylin Pharmaceuticals Inc | Efectos del peptido-1(7-36) tipo glucagon en la motilidad antro-piloro.duodenal. |
| YU68102A (sh) | 2000-03-16 | 2006-01-16 | F. Hoffmann-La Roche Ag. | Derivati karboksilne kiseline kao ip antagonisti |
| WO2002055484A1 (en) | 2001-01-12 | 2002-07-18 | Takeda Chemical Industries, Ltd. | Biaryl compound, process for producing the same, and agent |
| TWI316055B (https=) | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
| WO2003007888A2 (en) | 2001-07-20 | 2003-01-30 | Adipogenix, Inc. | Fat accumulation-modulating compounds |
| MXPA04001253A (es) | 2001-08-09 | 2004-06-03 | Ono Pharmaceutical Co | Derivados de acidos carboxilicos y agente farmaceutico que comprende los mismos como ingrediente activo. |
| TW200307539A (en) | 2002-02-01 | 2003-12-16 | Bristol Myers Squibb Co | Cycloalkyl inhibitors of potassium channel function |
| US7086532B2 (en) | 2003-07-16 | 2006-08-08 | Allergan, Inc. | Titration/compliance pack with increasing doses |
| TWI293715B (en) | 2002-10-10 | 2008-02-21 | Sipix Imaging Inc | A method for inducing or enhancing the threshold of an electrophoretic display, an electrophoretic fluid and an electrophoretic display |
| CN1735598A (zh) | 2002-11-11 | 2006-02-15 | 拜耳医药保健股份公司 | 作为ip受体拮抗剂的苯基或杂芳基氨基烷烃衍生物 |
| CN101723891A (zh) | 2003-02-10 | 2010-06-09 | 沃泰克斯药物股份有限公司 | 通过使n-芳基氨基甲酸酯与卤代杂芳基反应制备n-杂芳基-n-芳基胺的方法和类似方法 |
| CN1191831C (zh) * | 2003-05-20 | 2005-03-09 | 广州贝氏药业有限公司 | 复方阿替洛尔硝苯地平缓释制剂 |
| GB0317498D0 (en) | 2003-07-25 | 2003-08-27 | Pfizer Ltd | Compounds |
| CN100402495C (zh) | 2003-09-22 | 2008-07-16 | 弗·哈夫曼-拉罗切有限公司 | 氨基烷基酰胺取代的环己基衍生物 |
| JP4402413B2 (ja) | 2003-09-29 | 2010-01-20 | 財団法人２１あおもり産業総合支援センター | Ｕ字型化合物およびこれを含む液晶組成物 |
| DE102004006785A1 (de) | 2004-02-11 | 2005-09-08 | Mayr, Herbert, Prof. Dr. | Verfahren zur CC-Bindungsknüpfung zwischen elektrophilen Substraten und TT-Verbindungen in neutralen bis basischen wässrigen oder alkoholischen Lösungsmitteln ohne den Einsatz einer Lewis- oder Protonensäure |
| US20060063930A1 (en) | 2004-08-20 | 2006-03-23 | Agoston Gregory E | Compositions and methods comprising proteinase activated receptor antagonists |
| JP2006083085A (ja) | 2004-09-15 | 2006-03-30 | Kyowa Hakko Kogyo Co Ltd | 二環性ピリミジン誘導体の製造法およびその合成中間体 |
| JP4792731B2 (ja) | 2004-11-12 | 2011-10-12 | Ｄｉｃ株式会社 | 重合性液晶組成物及び当該組成物の硬化物 |
| WO2007051255A1 (en) | 2005-11-04 | 2007-05-10 | The University Of Sydney | Process for the preparation of compounds containing an azacyclic ring system |
| JP2007161867A (ja) | 2005-12-14 | 2007-06-28 | Toyo Ink Mfg Co Ltd | インキ組成物 |
| CN101489544A (zh) | 2006-05-09 | 2009-07-22 | 海玛奎斯特医药公司 | 治疗血液病的方法 |
| PE20080669A1 (es) * | 2006-09-08 | 2008-07-18 | Drugtech Corp | Composicion de liberacion sostenida que comprende levodopa |
| BRPI0717171B1 (pt) * | 2006-09-25 | 2023-10-17 | Archer Daniels Midland Company | Material superabsorvente |
| US20130084243A1 (en) * | 2010-01-27 | 2013-04-04 | Liliane Goetsch | Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders |
| US20110086916A1 (en) | 2007-09-12 | 2011-04-14 | Merz Pharma Gmbh & Co. Kgaa | Interval therapy for the treatment of tinnitus |
| KR20230085944A (ko) | 2008-03-18 | 2023-06-14 | 아레나 파마슈티칼스, 인크. | 프로스타시클린 （ｐｇｉ２） 수용체와 관련된 장애의 치료에 유용한 상기 수용체의 조절제 |
| EP2326306A1 (en) * | 2008-09-25 | 2011-06-01 | Cephalon, Inc. | Liquid formulations of bendamustine |
| JP5603343B2 (ja) | 2008-11-26 | 2014-10-08 | アリーナ ファーマシューティカルズ， インコーポレイテッド | 関連する障害を処置するために有用なプロスタサイクリン（ｐｇｉ２）受容体モジュレーターとしてのピラゾリル置換炭酸誘導体 |
| PT2370413E (pt) | 2008-12-08 | 2015-10-23 | Arena Pharm Inc | Moduladores do recetor da prostaciclina (pgi2) úteis para o tratamento de distúrbios relacionados com o mesmo |
| US20110028412A1 (en) * | 2009-08-03 | 2011-02-03 | Cappellos, Inc. | Herbal enhanced analgesic formulations |
| EP2480526A1 (en) | 2009-09-23 | 2012-08-01 | Arena Pharmaceuticals, Inc. | Crystalline forms and processes for the preparation of pgi2 receptor agonists |
| KR102221846B1 (ko) * | 2014-04-07 | 2021-02-26 | 영진약품 주식회사 | 안정성이 개선된 프레가발린을 함유하는 약제학적 조성물 및 이의 제조방법 |
| WO2016065103A1 (en) * | 2014-10-23 | 2016-04-28 | Arena Pharmaceuticals, Inc. | Method of treating conditions related to the pgi2 receptor |
| KR20260020212A (ko) | 2016-11-10 | 2026-02-10 | 아레나 파마슈티칼스, 인크. | 라리네팍 및 다른 제제의 조합에 의한 pah의 치료 방법 |
| EP3977985B1 (en) | 2017-03-01 | 2023-09-06 | Arena Pharmaceuticals, Inc. | Compositions comprising pgi2-receptor agonists and processes for the preparation thereof |
| WO2019222764A1 (en) | 2018-05-16 | 2019-11-21 | Arena Pharmaceuticals, Inc. | Compositions comprising pgi2-receptor agonists and processes for the preparation thereof |
-
2018
- 2018-03-01 EP EP21192192.9A patent/EP3977985B1/en active Active
- 2018-03-01 WO PCT/US2018/020519 patent/WO2018160882A1/en not_active Ceased
- 2018-03-01 JP JP2019546918A patent/JP7023559B2/ja active Active
- 2018-03-01 KR KR1020227027530A patent/KR20220119169A/ko not_active Ceased
- 2018-03-01 ES ES18710740T patent/ES2897024T3/es active Active
- 2018-03-01 IL IL268997A patent/IL268997B2/en unknown
- 2018-03-01 MA MA047686A patent/MA47686A/fr unknown
- 2018-03-01 EP EP18710740.4A patent/EP3589274B1/en active Active
- 2018-03-01 AU AU2018227842A patent/AU2018227842B2/en active Active
- 2018-03-01 CA CA3054835A patent/CA3054835A1/en active Pending
- 2018-03-01 CN CN201880029276.9A patent/CN110582271B/zh active Active
- 2018-03-01 ES ES21192192T patent/ES2965069T3/es active Active
- 2018-03-01 KR KR1020197028214A patent/KR102432505B1/ko active Active
-
2019
- 2019-04-16 US US16/386,183 patent/US11123298B2/en active Active
-
2021
- 2021-08-12 US US17/400,957 patent/US11826471B2/en active Active
-
2022
- 2022-02-07 JP JP2022017392A patent/JP7498202B2/ja active Active
-
2023
- 2023-10-20 US US18/491,529 patent/US20240285537A1/en active Pending
-
2024
- 2024-05-13 AU AU2024203156A patent/AU2024203156A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020510660A5 (https=) | ||
| KR102024955B1 (ko) | 치환된 시클로부텐디온 항염 화합물의 콜린 염 | |
| JP2013501718A5 (https=) | ||
| TW201446286A (zh) | 抗病毒化合物之固態分散調製劑 | |
| RU2017112308A (ru) | Композиции и способы для лечения бессонницы | |
| JP2014501267A (ja) | メサラジン制御放出用の経口用医薬錠剤および前記錠剤を得るための製法 | |
| US8753682B2 (en) | Dual release oral tablet compositions of dexlansoprazole | |
| US9114085B2 (en) | Modified release pharmaceutical compositions of dexlansoprazole | |
| JP2018516266A5 (https=) | ||
| CN102307575B (zh) | 含醋氯芬酸的控释口服药制剂及其制造方法 | |
| US8563035B2 (en) | Oral tablet compositions of dexlansoprazole | |
| EP2641594B1 (en) | Enteric coated solid pharmaceutical compositions for proton pump inhibitors | |
| WO2012144964A1 (en) | Thiocolchicoside, diclofenac and lansoprazole combinations | |
| JP2017214341A (ja) | 経口医薬製剤 | |
| JP6781561B2 (ja) | プロピオン酸系非ステロイド性消炎鎮痛薬を含有した医薬組成物 | |
| WO2002066030A1 (en) | Medicinal compositions comprising diclofenac and ornoprostil | |
| JP2021525704A5 (https=) | ||
| JP6334088B2 (ja) | 解熱鎮痛薬組成物 | |
| WO2014007777A1 (en) | Combined capsule formulations of nsaids | |
| WO2020094251A2 (en) | Treatment of portal hypertension and cirrhosis | |
| JP6903252B2 (ja) | キサンチンオキシダーゼ阻害剤含有腸溶性製剤 | |
| RU2786364C1 (ru) | Энтеросолюбильная таблетка, содержащая диметилфумарат | |
| WO2019098984A1 (en) | Synergistic combination of diclofenac, famotidine and a carbonate | |
| JPWO2019222764A5 (https=) | ||
| CN108883074A (zh) | 含有他达拉非和坦索罗辛并具有改善的稳定性和溶出率的复合胶囊制剂 |